Cargando…
Expression of TGF-β1/mTOR signaling pathway in pathological scar fibroblasts
The aim of the present study was to detect the expression of the key molecules, including transforming growth factor-β1 (TGF-β1), phosphatidylinositol 3-kinase (PI3K), protein kinase B (Akt) of TGF-β1/mammalian target of rapamycin (mTOR) pathway in pathological scar fibroblasts. Immunofluorescence,...
Autores principales: | Zhai, Xiao-Xiang, Tang, Zhi-Ming, Ding, Ji-Cun, Lu, Xiao-Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436288/ https://www.ncbi.nlm.nih.gov/pubmed/28393182 http://dx.doi.org/10.3892/mmr.2017.6437 |
Ejemplares similares
-
Expression of mTOR/70S6K signaling pathway in pathological scar fibroblasts and the effects of resveratrol intervention
por: Tang, Zhi-Ming, et al.
Publicado: (2017) -
Xanthohumol Inhibits TGF-β1-Induced Cardiac Fibroblasts Activation via Mediating PTEN/Akt/mTOR Signaling Pathway
por: Jiang, Chuanhao, et al.
Publicado: (2020) -
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020) -
Dendrite pathology and neurodegeneration: focus on mTOR
por: Di Polo, Adriana
Publicado: (2015) -
Expression of mTOR in normal and pathological conditions
por: Marques-Ramos, A, et al.
Publicado: (2023)